Page 379 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 379

CHAPTER 20  Drugs Used in Asthma     365


                    Treatment of COPD                                    Kew KM, Dias S, Cates CJ: Long-acting inhaled therapy (beta-agonists, anti-
                                                                             cholinergics and steroids) for COPD: A network meta-analysis. Cochrane
                    Global Initiative for Chronic Obstructive Lung Disease: Global Strategy   Database Syst Rev 2014;1:CD010844.
                        for Diagnosis, Management, and Prevention of COPD. http://www   Niewoehner DE: Clinical practice. Outpatient management of severe COPD.
                        .goldcopd.org.                                       N Engl J Med 2010;362:1407.
                    Huisman EL et al: Comparative efficacy of combination bronchodilator therapies   Vogelmeier C et al: Tiotropium versus salmeterol for the prevention of exacerba-
                        in COPD: A network meta-analysis. Int J Chron Obstruct Pulmon Dis   tions of COPD. N Engl J Med 2011;364:1093.
                        2015;10:1863.




                       C ASE  STUD Y  ANSWER

                       This patient demonstrates the destabilizing effects of a   patient and her parents need instruction on the importance
                       respiratory infection on asthma, and her mother’s comments   of regular adherence to therapy, with reassurance that it can
                       demonstrate the common (and dangerous) phobia about   be “stepped down” to a lower dose of inhaled corticosteroid
                       “overuse” of bronchodilator or steroid inhalers. The patient   (although still in combination with a long-acting β agonist)
                       has signs of imminent respiratory failure, including her   once her condition stabilizes. They also need instruction
                       refusal to lie down, her fear, and her tachycardia, which can-  on an action plan for managing severe symptoms. This
                       not be attributed to her minimal treatment with albuterol.   can be as simple as advising that if the patient has a severe,
                       Critically important immediate steps are to administer high-  frightening attack, she can take up to four puffs of albuterol
                       flow oxygen and to start albuterol by nebulization. Adding   every 15 minutes, but if the first treatment does not bring
                       ipratropium (Atrovent) to the nebulized solution is recom-  significant relief, she should take the next four puffs while on
                       mended.  A  corticosteroid  (0.5–1.0  mg/kg  of  methylpred-  her way to an emergency department or urgent care clinic.
                       nisolone) should be administered intravenously. It is also   She should also be given a prescription for prednisone, with
                       advisable to alert the intensive care unit, because a patient   instructions to take 40–60 mg orally for severe attacks, but
                       with severe bronchospasm who tires can slip into respiratory   not to wait for it to take effect if she remains severely short of
                       failure quickly, and intubation can be difficult.  breath even after albuterol inhalations. Asthma is a chronic
                         Fortunately, most patients treated in hospital emergency   disease, and good care requires close follow-up and creation
                       departments do well. Asthma mortality is rare (fewer than   of a provider-patient partnership for optimal management.
                       4000 deaths per year among a population of more than   If she has had several previous exacerbations, she should be
                       20 million asthmatics in the USA), and when it occurs, it   considered a candidate for monoclonal anti-IgE antibody
                       is  often  out  of  hospital.  Presuming  this  patient  recovers,   therapy with omalizumab, which effectively reduces the
                       she needs adjustments to her therapy before discharge. The   rate of asthma exacerbations—even those associated with
                       strongest predictor of severe attacks of asthma is their occur-  viral respiratory infection—in patients with allergic asthma.
                       rence in the past. Thus, this patient’s therapy needs to be   Alternatively, if the patient is found to have blood eosino-
                       stepped up to a higher level, like a high-dose inhaled cortico-  philia, treatment with an anti-IL-5 monoclonal antibody (eg,
                       steroid in combination with a long-acting β agonist. Both the   mepolizumab) should be considered as well.
   374   375   376   377   378   379   380   381   382   383   384